Comparison of Molecular Signatures from Multiple Skin Diseases Identifies Mechanisms of Immunopathogenesis
暂无分享,去创建一个
Matteo Pellegrini | William R. Swindell | Philip O. Scumpia | David Lopez | James T. Elder | M. Pellegrini | T. Graeber | P. Scumpia | M. Gilliet | S. Meller | David López | B. Homey | W. Swindell | Bernhard Homey | R. Modlin | Thomas G. Graeber | Robert L. Modlin | Michel Gilliet | Rosane M B Teles | Megan S. Inkeles | Rosane M.B. Teles | Stephan Meller | Rosane M. B. Teles
[1] James McCluskey,et al. Human leukocyte antigen-associated drug hypersensitivity. , 2013, Current opinion in immunology.
[2] P. van Erp,et al. Molecular diagnostics of psoriasis, atopic dermatitis, allergic contact dermatitis and irritant contact dermatitis , 2010, The British journal of dermatology.
[3] R. Freire,et al. Interferon-induced sarcoidosis , 2011, BMJ Case Reports.
[4] Jun Yan,et al. New insights of T cells in the pathogenesis of psoriasis , 2012, Cellular and Molecular Immunology.
[5] Rafael A Irizarry,et al. Frozen robust multiarray analysis (fRMA). , 2010, Biostatistics.
[6] J. Ring,et al. Mutual antagonism of T cells causing psoriasis and atopic eczema. , 2011, The New England journal of medicine.
[7] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[8] Mayte Suárez-Fariñas,et al. Expanding the Psoriasis Disease Profile: Interrogation of the Skin and Serum of Patients with Moderate-to-Severe Psoriasis , 2012, The Journal of investigative dermatology.
[9] James T. Elder,et al. Heterogeneity of Inflammatory and Cytokine Networks in Chronic Plaque Psoriasis , 2012, PloS one.
[10] P. Brown,et al. Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and Heterogeneity across Diseases , 2012, PloS one.
[11] J. Krutmann,et al. Lesional expression of interferon-gamma in atopic eczema. , 1994, Lancet.
[12] Andrew Johnston,et al. Transcriptome analysis of psoriasis in a large case-control sample: RNA-seq provides insights into disease mechanisms , 2014, The Journal of investigative dermatology.
[13] W. Fujimoto,et al. Differential Expression of Human Cornifin α and β in Squamous Differentiating Epithelial Tissues and Several Skin Lesions. , 1997 .
[14] A. Irvine,et al. Filaggrin in atopic dermatitis. , 2008, The Journal of allergy and clinical immunology.
[15] Brad T. Sherman,et al. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.
[16] Andrew Johnston,et al. Dissecting the psoriasis transcriptome: inflammatory- and cytokine-driven gene expression in lesions from 163 patients , 2013, BMC Genomics.
[17] R. Clark,et al. IL-15 and dermal fibroblasts induce proliferation of natural regulatory T cells isolated from human skin. , 2007, Blood.
[18] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[19] Andreas Rytz,et al. The limit fold change model: A practical approach for selecting differentially expressed genes from microarray data , 2002, BMC Bioinformatics.
[20] Yuan-Tsong Chen,et al. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis , 2008, Nature Medicine.
[21] A. Bowcock,et al. Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities. , 2011, The Journal of allergy and clinical immunology.
[22] J. Krutmann,et al. Lesional expression of interferon-γ in atopic eczema , 1994, The Lancet.
[23] Q. Hamid,et al. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. , 1994, The Journal of clinical investigation.
[24] Virginia Pascual,et al. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. , 2008, Immunity.
[25] W. Fujimoto,et al. Differential expression of human cornifin alpha and beta in squamous differentiating epithelial tissues and several skin lesions. , 1997, The Journal of investigative dermatology.
[26] A. Nanda. Concomitance of psoriasis and atopic dermatitis. , 1995, Dermatology.
[27] Yihong Yao,et al. Type I Interferon: Potential Therapeutic Target for Psoriasis? , 2008, PloS one.
[28] T. Graeber,et al. Type I Interferon Suppresses Type II Interferon–Triggered Human Anti-Mycobacterial Responses , 2013, Science.
[29] A. Grassegger,et al. Significance of the cytokine interferon gamma in clinical dermatology , 2004, Clinical and experimental dermatology.
[30] A. Wahba-Yahav. Disease concomitance in psoriasis. , 1996, Journal of the American Academy of Dermatology.
[31] Alex E. Lash,et al. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..
[32] Defining protective responses to pathogens: cytokine profiles in leprosy lesions. , 1991, Science.
[33] Y. Tu,et al. Quantitative noise analysis for gene expression microarray experiments , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[34] M. Marques,et al. Mycosis fungoides and Sézary syndrome: clinical, histopathological and immunohistochemical review and update , 2012, Anais brasileiros de dermatologia.
[35] S. Skurkovich,et al. Inhibition of IFN-gamma as a method of treatment of various autoimmune diseases, including skin diseases. , 2006, Ernst Schering Research Foundation workshop.
[36] Martine Bagot,et al. Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. , 2004, The Journal of allergy and clinical immunology.
[37] J. Krutmann,et al. Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients. , 1995, The Journal of investigative dermatology.
[38] P. Brown,et al. Dissecting Interferon-Induced Transcriptional Programs in Human Peripheral Blood Cells , 2010, PloS one.